schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".

former novartis exec to lead cambridge diabetes startup semma.

.

.

follow dailymail

.

advertisement

.

webmd network.

copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.